ethoxyresorufin has been researched along with bradykinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulton, D; McGiff, JC; Quilley, J | 1 |
| Cocks, TM; Drummond, GR; Selemidis, S | 1 |
2 other study(ies) available for ethoxyresorufin and bradykinin
| Article | Year |
|---|---|
Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetylcholine; Animals; Arginine; Blood Pressure; Body Weight; Bradykinin; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Oxazines; Rats; Rats, Wistar; Renal Circulation; Vasodilator Agents | 1992 |
Apamin-sensitive, non-nitric oxide (NO) endothelium-dependent relaxations to bradykinin in the bovine isolated coronary artery: no role for cytochrome P450 and K+.
Topics: Animals; Apamin; Arachidonic Acid; Arachidonic Acids; Biological Factors; Bradykinin; Cattle; Coronary Vessels; Cromakalim; Cyclohexanones; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Ouabain; Oxazines; Potassium; Potassium Chloride; Protease Inhibitors | 2000 |